Discover relevant emerging drug programs that match your investment criteria and monitor them as they progress through pre-defined research and development phases from pre-IND through trial enrollments and approval. By combining financial, news, conference abstracts, drug development and biomarker data into a unified profile, you can get alerted to that next blockbuster before that big press release hits the wire.
The path to drug approval is fraught with scientific challenges and competitors progressing through clinical trials. Amplion’s contextual machine learning coalesces the competitive landscape across multiple dimensions – including biomarker, disease, test and development activity – so you can make informed choices and improve ROI.
By leveraging Amplion's targeted machine learning and detailed investment criteria, you can track all th R&D activity that matches your investment profile, including early stage research, press announcements, clinical trial progression, partnerships, M&A and funding..